Nordic Nanovector Starting Pivotal Trial With Lead Asset Betalutin In R/R FL

 
• By Sten Stovall
  
Leukemia cell (blast cell)
Betalutin is a potential new targeted treatment for patients with non-Hodgkin’s lymphoma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category